Tower Research Capital LLC (Trc) Rocket Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,120 shares of RCKT stock, worth $9,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,120
Previous 34,187
90.87%
Holding current value
$9,079
Previous $429,000
95.34%
% of portfolio
0.0%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding RCKT
# of Institutions
224Shares Held
105MCall Options Held
437KPut Options Held
117K-
Rtw Investments, LP New York, NY17.7MShares$51.5 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$36.7 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$17.8 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$15.1 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $220M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...